Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

Double-blind, Placebo-controlled Dose-finding Study With CYT003-QbG10 in Adult Patients With Rhinoconjunctivitis Due to House Dust Mite Allergy

The purpose of the study is to test whether vaccinations with CYT003-QbG10 can improve allergy symptoms in patients with house dust mite allergy. The active treatment will be compared against placebo.

Inclusion Criteria:

• Perennial allergic rhinoconjunctivitis due to clinically relevant allergy towards house dust mite allergens
• Further criteria as defined in the study protocol

Exclusion Criteria:

• Clinically manifested seasonal allergy/-ies which is/are expected to interfere with the patient's study treatment schedule and/or assessments
• Clinically relevant perennial allergy/-ies other than house dust mites allergy
• Contraindication to any study test or procedure
• Further criteria as defined in the study protocol